Fresh analysis indicates that individuals who stop using popular slimming jabs like semaglutide or tirzepatide may regain shed pounds much more quickly than those who stop conventional diet and exercise programs.
Published data in a leading health publication demonstrates that while obese people frequently drop about a fifth of their total mass while on the medication, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing such drugs need to be cognizant of the potential of rapid rebound weight gain when the medication ends," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery means a reversion to starting mass within about 18 months.
Weighing Treatments
The analysis, which reviewed 37 of trials involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with older methods.
Researchers note that people who shed pounds through diet and exercise usually see a slower creep back—approximately 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Nutrition scientists believe the mechanism of the injections is key to understanding the amplified weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement means appetite is unsuppressed, making binge eating a significant risk."
A Chronic Issue?
Health authorities advise the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts say that, due to the likelihood of relapse, the treatment is often ongoing.
This opinion is echoed by pharmaceutical companies, who note that the results "underscore the chronic character of obesity," akin to managing diseases like high blood pressure.
Patient Accounts
Individuals who have come off the jabs describe a intense return of cravings.
"I experienced something that goes on and you become ravenous," described an individual.
This challenge is exacerbated if users have not adopted lasting lifestyle or habit changes during treatment.
Significant Use
Survey data suggest that a significant number of adults in the UK have used these injections in the last 12 months, with demand being substantial.
- Adoption is more common among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
Ultimately, clinicians caution that while the jabs are powerful tools for shedding pounds, they are not a standalone fix and maintained weight loss hinges on combined lifestyle support.